{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T11:46:11Z","timestamp":1767181571996,"version":"build-2238731810"},"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T00:00:00Z","timestamp":1522281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Crohn's and Colitis Organization"},{"DOI":"10.13039\/100001063","name":"Crohn's and Colitis Foundation of America","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001063","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0194222","type":"journal-article","created":{"date-parts":[[2018,3,29]],"date-time":"2018-03-29T13:33:00Z","timestamp":1522330380000},"page":"e0194222","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":6,"title":["Serum anti-glycan-antibodies in relatives of patients with inflammatory bowel disease"],"prefix":"10.1371","volume":"13","author":[{"given":"Florian","family":"Kamm","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrike","family":"Strauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frauke","family":"Degenhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rocio","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Rogler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andre","family":"Franke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Klebl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9087-1568","authenticated-orcid":true,"given":"Florian","family":"Rieders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2018,3,29]]},"reference":[{"issue":"1","key":"ref1","first-page":"13","article-title":"Immunopathogenesis of IBD: current state of the art","volume":"13","author":"HS de Souza","year":"2016","journal-title":"Nature reviews"},{"issue":"3","key":"ref2","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.bpg.2003.12.006","article-title":"IBD: a family affair","volume":"18","author":"RK Russell","year":"2004","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1053\/gast.2003.50045","article-title":"The genetics of inflammatory bowel disease","volume":"124","author":"DK Bonen","year":"2003","journal-title":"Gastroenterology"},{"issue":"6837","key":"ref4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/35079107","article-title":"Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease","volume":"411","author":"JP Hugot","year":"2001","journal-title":"Nature"},{"issue":"2","key":"ref5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0016-5085(98)70476-7","article-title":"Early lesions of recurrent Crohn's disease caused by infusion of intestinal contents in excluded ileum","volume":"114","author":"GR D'Haens","year":"1998","journal-title":"Gastroenterology"},{"issue":"7\u20138","key":"ref6","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1023\/B:DDAS.0000037824.66186.e2","article-title":"High-level serum antibodies to bacterial antigens are associated with antibiotic-induced clinical remission in Crohn's disease: a pilot study","volume":"49","author":"WS Mow","year":"2004","journal-title":"Dig Dis Sci"},{"issue":"2","key":"ref7","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1053\/j.gastro.2006.04.030","article-title":"Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease","volume":"131","author":"I Dotan","year":"2006","journal-title":"Gastroenterology"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1053\/j.gastro.2005.03.046","article-title":"Antibodies to CBir1 flagellin define a unique response that is associated independently with complicated Crohn's disease","volume":"128","author":"SR Targan","year":"2005","journal-title":"Gastroenterology"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1053\/gast.2002.35379","article-title":"Selected loss of tolerance evidenced by Crohn's disease-associated immune responses to auto- and microbial antigens","volume":"123","author":"CJ Landers","year":"2002","journal-title":"Gastroenterology"},{"issue":"9","key":"ref10","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1172\/JCI200420295","article-title":"Bacterial flagellin is a dominant antigen in Crohn disease","volume":"113","author":"MJ Lodes","year":"2004","journal-title":"The Journal of clinical investigation"},{"issue":"2","key":"ref11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/ibd.21046","article-title":"Association of the novel serologic anti-glycan antibodies anti-laminarin and anti-chitin with complicated Crohn's disease behavior","volume":"16","author":"F Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"3","key":"ref12","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1572-0241.2007.01652.x","article-title":"New serological markers for inflammatory bowel disease are associated with earlier age at onset, complicated disease behavior, risk for surgery, and NOD2\/CARD15 genotype in a Hungarian IBD cohort","volume":"103","author":"M Papp","year":"2008","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"ref13","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1136\/gut.2006.108043","article-title":"New serological markers in inflammatory bowel disease are associated with complicated disease behaviour","volume":"56","author":"M Ferrante","year":"2007","journal-title":"Gut"},{"issue":"8","key":"ref14","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/ibd.21179","article-title":"Serum anti-glycan antibodies predict complicated Crohn's disease behavior: a cohort study","volume":"16","author":"F Rieder","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"ref15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/ajg.2009.79","article-title":"Novel anti-glycan antibodies related to inflammatory bowel disease diagnosis and phenotype","volume":"104","author":"CH Seow","year":"2009","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"ref16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/S0016-5085(97)70174-4","article-title":"Clustering of increased small intestinal permeability in families with Crohn's disease","volume":"113","author":"M Peeters","year":"1997","journal-title":"Gastroenterology"},{"issue":"6","key":"ref17","doi-asserted-by":"crossref","first-page":"883","DOI":"10.7326\/0003-4819-105-6-883","article-title":"Increased intestinal permeability in patients with Crohn's disease and their relatives. A possible etiologic factor","volume":"105","author":"D Hollander","year":"1986","journal-title":"Ann Intern Med"},{"issue":"5","key":"ref18","doi-asserted-by":"crossref","first-page":"e18172","DOI":"10.1371\/journal.pone.0018172","article-title":"Characterization of changes in serum anti-glycan antibodies in Crohn's disease\u2014a longitudinal analysis","volume":"6","author":"F Rieder","year":"2010","journal-title":"PLoS One"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ecco-jcc\/jjw168","article-title":"3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 1: Diagnosis and Medical Management","volume":"11","author":"F Gomollon","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"key":"ref20","article-title":"Third European Evidence-Based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","author":"F Magro","year":"2017","journal-title":"Journal of Crohn's & colitis"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1002\/ibd.20054","article-title":"Predictors of early response to infliximab in patients with ulcerative colitis","volume":"13","author":"M Ferrante","year":"2007","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"ref22","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1136\/gut.46.1.58","article-title":"Familial expression of anti-Saccharomyces cerevisiae mannan antibodies in affected and unaffected relatives of patients with Crohn's disease","volume":"46","author":"CL Sutton","year":"2000","journal-title":"Gut"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1159\/000066760","article-title":"Anti-saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease and their first-degree relatives: potential clinical value","volume":"66","author":"J Glas","year":"2002","journal-title":"Digestion"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/j.1572-0241.2001.04043.x","article-title":"Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study","volume":"96","author":"V Annese","year":"2001","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"ref25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00054725-200102000-00002","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA), phenotypes of IBD, and intestinal permeability: a study in IBD families","volume":"7","author":"S Vermeire","year":"2001","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"ref26","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1080\/003655201750065960","article-title":"Anti-Saccharomyces cerevisiae antibodies in inflammatory bowel disease: a family study","volume":"36","author":"F Seibold","year":"2001","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"8","key":"ref27","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1111\/j.1572-0241.1998.00415.x","article-title":"Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease","volume":"93","author":"B Sendid","year":"1998","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"ref28","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/00365520601083625","article-title":"Ethnic and socio-cultural specificities in Tunisia have no impact on the prevalence of anti-Saccharomyces cerevisiae antibodies in Crohn's disease patients, their relatives or associated clinical factors","volume":"42","author":"I Hadrich","year":"2007","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"4","key":"ref29","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1053\/j.gastro.2006.02.013","article-title":"Familial expression of anti-Escherichia coli outer membrane porin C in relatives of patients with Crohn's disease","volume":"130","author":"L Mei","year":"2006","journal-title":"Gastroenterology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0016-5085(97)70085-4","article-title":"Goblet cell autoantibodies in patients with inflammatory bowel disease and their first-degree relatives","volume":"113","author":"C Folwaczny","year":"1997","journal-title":"Gastroenterology"},{"issue":"10","key":"ref31","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1136\/gut.32.10.1192","article-title":"Antibodies to a trypsin sensitive pancreatic antigen in chronic inflammatory bowel disease: specific markers for a subgroup of patients with Crohn's disease","volume":"32","author":"F Seibold","year":"1991","journal-title":"Gut"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/gut.47.6.870a","article-title":"Mother to child transmission of anti-S cerevisiae mannan antibodies (ASCA) in non-IBD families","volume":"47","author":"D Poulain","year":"2000","journal-title":"Gut"},{"issue":"6","key":"ref33","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1080\/00365520212511","article-title":"Familial and sporadic inflammatory bowel disease: comparison of clinical features and serological markers in a genetically homogeneous population","volume":"37","author":"L Halme","year":"2002","journal-title":"Scandinavian journal of gastroenterology"},{"issue":"1","key":"ref34","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ibd.20985","article-title":"Familial aggregation and antimicrobial response dose-dependently affect the risk for Crohn's disease","volume":"16","author":"M Joossens","year":"2010","journal-title":"Inflamm Bowel Dis"},{"issue":"6","key":"ref35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/00042737-200306000-00003","article-title":"Lessons to be learned from the NOD2 gene in Crohn's disease","volume":"15","author":"JP Hugot","year":"2003","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"3","key":"ref36","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.bbagen.2007.09.008","article-title":"Anti-GM1 antibodies as a model of the immune response to self-glycans","volume":"1780","author":"GA Nores","year":"2008","journal-title":"Biochim Biophys Acta"}],"updated-by":[{"DOI":"10.1371\/journal.pone.0203709","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:00:00Z","timestamp":1536019200000}}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0194222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:55:58Z","timestamp":1589021758000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0194222"}},"subtitle":[],"editor":[{"given":"John","family":"Green","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2018,3,29]]},"references-count":36,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,3,29]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0194222","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,29]]}}}